Literature DB >> 7741052

[Effects of bromfenac sodium, non-steroidal anti-inflammatory drug, on acute ocular inflammation].

T Ogawa1, T Sakaue, T Terai, C Fukiage.   

Abstract

We studied the effects of bromfenac sodium (BF) on several types of acute ocular inflammation. BF inhibited the production of prostaglandins from rabbit iris-ciliary body by 50% at a concentration of 1.1 microM and was 3.8 and 10.9 times more potent than indomethacin (IM) and pranoprofen (PPF), respectively. BF inhibited both arachidonic acid- and carrageenan-induced conjunctival edema in rats in a dose-dependent manner. The ranking order of antiinflammatory drugs for inhibition in arachidonic acid- and carrageenan-induced conjunctival edema was BF = PPF > dexamethasone (DM) and BF > or = DM > PPF, respectively. BF inhibited an increase of aqueous protein after paracentesis in pigmented rabbits by 50% at a concentration of 0.0054% and was 8.1 and 4.1 times more potent than PPF and IM, respectively, BF inhibited an increase of aqueous protein after laser irradiation of pigmented rabbit iris by 50% at a concentration of 0.009% and was approximately 10 times more potent than PPF. These results suggest that BF may be a useful drug in therapy for conjunctivitis and post-operative inflammation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7741052

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  6 in total

1.  Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost in patients with primary open angle glaucoma or ocular hypertension.

Authors:  T Chiba; K Kashiwagi; N Chiba; S Tsukahara
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

Review 2.  Clinical pharmacokinetics and pharmacodynamics of bromfenac.

Authors:  N M Skjodt; N M Davies
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

3.  Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost.

Authors:  K Kashiwagi; S Tsukahara
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

Review 4.  Cataract surgery and nonsteroidal antiinflammatory drugs.

Authors:  Richard S Hoffman; Rosa Braga-Mele; Kendall Donaldson; Geoffrey Emerick; Bonnie Henderson; Malik Kahook; Nick Mamalis; Kevin M Miller; Tony Realini; Neal H Shorstein; Richard K Stiverson; Barbara Wirostko
Journal:  J Cataract Refract Surg       Date:  2016-09       Impact factor: 3.351

Review 5.  Topical ocular delivery of NSAIDs.

Authors:  Munish Ahuja; Avinash S Dhake; Surendra K Sharma; Dipak K Majumdar
Journal:  AAPS J       Date:  2008-04-25       Impact factor: 4.009

6.  Pharmacokinetics and efficacy of topically applied nonsteroidal anti-inflammatory drugs in retinochoroidal tissues in rabbits.

Authors:  Tetsuo Kida; Seiko Kozai; Hiroaki Takahashi; Mitsuyoshi Isaka; Hideki Tokushige; Taiji Sakamoto
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.